This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

JOHN HORTON, MB, ChB; KENNETH B. OLSON, MD; HENRY F. HOSLEY, MD

Arch Intern Med. 1966;117(6):775-777.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

FLUOROURACIL has found a definite place in the treatment of advanced cancer, especially those tumors primary in the breast or colon.¹ Probably the most disturbing toxic manifestation of this drug is the development of severe and occasionally lethal granulocytopenia. Once this state has developed, opinions vary as to the best form of therapy that will ensure or aid in recovery. Antibiotics are usually given but then the question as to whether corticosteroid drugs should be administered is frequently raised. There is inconclusive evidence that corticosteroids will adversely affect myelogenous leukemia ^2,3 and even less evidence that they will "stimulate" an already depressed or aplastic bone marrow^4,5 nearly devoid of granulocytes.

The purpose of this study was to determine whether the concurrent administration of a potent corticosteroid drug (methylprednisolone) with conventional courses of intravenous fluorouracil would protect the bone marrow and other normal tissues from the toxic effects of . . . [Full Text PDF of this Article]

Author Affiliations
ALBANY, NY

From the Department of Medicine, Subdepartment of Oncology, Albany Medical College, Albany. Dr. Horton is a Senior Clinical Trainee, Cancer Control Program, US Public Health Service.

Footnotes
Received for publication Oct 8, 1965; accepted Jan 28, 1966.

Reprint requests to the Albany Medical College of Union University, Albany, NY (Dr. Olson).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?